Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Integrated genomic and immunophenotypic profiling of histiocytic disorders reveals therapeutic implications of differential BCL2 expression

Hind Salama, Yasir M. Alsubhi, Mohammed Omer, Saeed Alshieban, Danah Awwadh AlHarthi, Tahani M. AlHalouly, Mohsen Alzahrani, Mohammad Alkaiyat, Ibraheem Motabi

Blood (2025) 146 (Supplement 1): 2986.

https://doi.org/10.1182/blood-2025-2986

Published: 2025

Journal Articles

CD 34 stem cell boost in patients with poor graft function after allogeneic hematopoietic stem cell transplantation: Experience from a tertiary care center

Nada Alshaikh, Mohammed Essa, Bader Alahmari, Ayman Almozaini, Walid Mashaqbeh, Rodaina Abujoub, Husam Alsadi, Memon Shahbaz, Dunia Jawdat, Tahani ELfadul, Khalid AlHarbi, Rahaf Salem, Khalid Almutairi, Mohsen Alzahrani

Blood (2025) 146 (Supplement 1): 7723.

https://doi.org/10.1182/blood-2025-7723

Published: 2025

Journal Articles

Secondary malignancies after hematopoietic cell transplantation for sickle cell disease: A single-center experience

Blood (2025) 146 (Supplement 1): 6037.

https://doi.org/10.1182/blood-2025-6037

Published: 2025

Journal Articles

Letermovir cytomegalovirus prophylaxis in hematopoietic-cell transplantation; Real world evidence from high endemic regions.

Rahaf Salem, Lama Alhmaly, Bader Alahmari, Ahmed Alaskar, Husam AlSadi, Ayman Almozaini, Ayman Hejazi, Abdullah S. Al Saleh, Khalid AlHarbi, Mashael AlMutairi, Mazin Ahmed, Nourah Alshuraym, MAYBELLE BALILI, Mohsen Alzahrani

Blood (2025) 146 (Supplement 1): 4277.

https://doi.org/10.1182/blood-2025-4277

Published: 2025

Journal Articles

The fertility outcome in a cohort of SCD patients undergoing haploidentical allogeneic stem cell transplant using NMA regimen.

Blood (2025) 146 (Supplement 1): 2485.

https://doi.org/10.1182/blood-2025-2485

Published: 2025

Journal Articles

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Blood (2025) 146 (Supplement 1): 4284.

https://doi.org/10.1182/blood-2025-4284

Published: 2025

Journal Articles

Clinical characteristics and outcome of diffuse large B-cell lymphoma: Real world data from Saudi Arabia

Abdullah Alrajhi, Mohsen Alzahrani, Muhned Alhumaid, Jude Howaidi, Batool Sharbek, Aysha Masri, Amal Alotaibi, Arwa Alhajj, Tariq Alqahtani, Raghad Alajmi, Ruyuf Alshuqayr, Sadeem Alamri, Ahmed Alaskar, Nada Alsuhebany

Blood (2025) 146 (Supplement 1): 1893.

https://doi.org/10.1182/blood-2025-1893

Published: 2025

Journal Articles

Short and Long-Term Toxicities of Allogeneic Stem Cell Transplant for Adult Patients with Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2024-194049

Published: 2024

Journal Articles

Outpatient Hematopoietic Stem Cell Transplant for Adult Sickle Cell Disease Patients Is Safe, Reduce Inpatient Bed Utilization and Improve Access to Care

Blood (2024) 144 (Supplement 1): 518.

https://doi.org/10.1182/blood-2024-198792

Published: 2024

Journal Articles

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Blood (2024) 143 (25): 2654–2665.

https://doi.org/10.1182/blood.2023023301

Published: 2024

Includes: Supplemental data

Journal Articles

Comparison of Interobserver Agreement between the 4T and the HIT Expert Probability (HEP) Scores: We Agreed Not to Agree

Abdulrahman Al Raizah, Rawan Almohamdy, Khalid Alharbi, Albarra Madkhali, Rahaf ElHussein Salem, Mohammed Alshuaibi, Abdullah S. Al Saleh, Mohsen Alzahrani, Ayman Hejazi, Hind Salama, Ahmed Alaskar

Blood (2023) 142 (Supplement 1): 5430.

https://doi.org/10.1182/blood-2023-181649

Published: 2023

Journal Articles

Clinical Features and Outcomes of Hemophagocytic Lymphohistiocytosis Secondary to Lymphoma: Insights from a Tertiary Center in Saudi Arabia

Rahaf ElHussein Salem, Mohamed H. Omer, Hind Salama, Ayman Alhejazi, Ayman Ibrahim, Sara Qubaiban, Abdulaziz Abdullah Alahmary, Maryam AlMutairi, Abdulrahman Al Raizah, Mohsen Alzahrani, Ahmed Alaskar

Blood (2023) 142 (Supplement 1): 6278.

https://doi.org/10.1182/blood-2023-188397

Published: 2023

Journal Articles

Impact of Genetic Variations on Thrombotic Risk in Saudis with Sickle Cell Disease

Farjah Algahtani, Mohammad Alshabeeb, Mohsen Alzahrani, Deemah Alwadaani, Hala Alajmi, Salah Abohelaika, Hussain Alsaeed, Mamoon Rashid, Barrak Alsomaie, Abdullah Alzayed, Ann Daly

Blood (2023) 142 (Supplement 1): 5553.

https://doi.org/10.1182/blood-2023-190003

Published: 2023

Journal Articles

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Reem Alasbali, Mohsen Alzahrani, Saud Alhayli, Walid Rasheed, Phavina Akhom, Karina Wilkerson, Mohammed Essa, Riad Elfakih, Bader Alahmari, Hadeel Samarkandi, Syed Osman Ahmed, Ayman Saad, Hazza A. Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Adetola A. Kassim, Ali D Alahmari

Blood (2023) 142 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2023-189914

Published: 2023

Journal Articles

Favorable Fertility Outcome in a Large Cohort of Sickle Cell Disease Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 240.

https://doi.org/10.1182/blood-2023-178128

Published: 2023

Journal Articles

Sickle Cell Disease (SCD) Burden on Patients Treated With Hydroxyurea (HU): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)

Hatoon M. Ezzat, Abdullah Hasan Al Zayed, Hussain H. Al Saeed, Mohamed Al Darwish, Muneer Albagshi, Hafiz Malhan, Ahmad Tarawah, Aljawhara Al Manea, Iman Alhazmi, Mohamed Qari, Azzah Alzahrani, Mohsen Alzahrani, Wesam Soliman, Farid Askar, Al Shaimaa Yassin, Wasil Jastaniah

Blood (2022) 140 (Supplement 1): 10879–10880.

https://doi.org/10.1182/blood-2022-166723

Published: 2022

Journal Articles

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Blood (2022) 140 (Supplement 1): 7599–7600.

https://doi.org/10.1182/blood-2022-158787

Published: 2022

Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Blood (2022) 140 (Supplement 1): 2383–2385.

https://doi.org/10.1182/blood-2022-165229

Published: 2022

Journal Articles

Evidence Gaps in the Management of Patients with Sickle Cell Disease (SCD) by Non-specialist Healthcare Professionals (HCPs): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)

Wasil Jastaniah, Abdullah Hasan Al Zayed, Hussain H. Al Saeed, Mohamed Al Darwish, Muneer Albagshi, Hafiz Malhan, Ahmad Tarawah, Aljawhara Al Manea, Iman Alhazmi, Mohamed Qari, Azzah Alzahrani, Mohsen Alzahrani, Wesam Soliman, Farid Askar, Sukina Almustafa, Hatoon M. Ezzat

Blood (2022) 140 (Supplement 1): 5133–5134.

https://doi.org/10.1182/blood-2022-166880

Published: 2022

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar

Blood (2022) 140 (Supplement 1): 12220–12221.

https://doi.org/10.1182/blood-2022-168926

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Integrated genomic and immunophenotypic profiling of histiocytic disorders reveals therapeutic implications of differential BCL2 expression

CD 34 stem cell boost in patients with poor graft function after allogeneic hematopoietic stem cell transplantation: Experience from a tertiary care center

Secondary malignancies after hematopoietic cell transplantation for sickle cell disease: A single-center experience

Letermovir cytomegalovirus prophylaxis in hematopoietic-cell transplantation; Real world evidence from high endemic regions.

The fertility outcome in a cohort of SCD patients undergoing haploidentical allogeneic stem cell transplant using NMA regimen.

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Clinical characteristics and outcome of diffuse large B-cell lymphoma: Real world data from Saudi Arabia

Short and Long-Term Toxicities of Allogeneic Stem Cell Transplant for Adult Patients with Sickle Cell Disease

Outpatient Hematopoietic Stem Cell Transplant for Adult Sickle Cell Disease Patients Is Safe, Reduce Inpatient Bed Utilization and Improve Access to Care

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Comparison of Interobserver Agreement between the 4T and the HIT Expert Probability (HEP) Scores: We Agreed Not to Agree

Clinical Features and Outcomes of Hemophagocytic Lymphohistiocytosis Secondary to Lymphoma: Insights from a Tertiary Center in Saudi Arabia

Impact of Genetic Variations on Thrombotic Risk in Saudis with Sickle Cell Disease

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Favorable Fertility Outcome in a Large Cohort of Sickle Cell Disease Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Sickle Cell Disease (SCD) Burden on Patients Treated With Hydroxyurea (HU): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Evidence Gaps in the Management of Patients with Sickle Cell Disease (SCD) by Non-specialist Healthcare Professionals (HCPs): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only